Behrens
Achim Behrens, Asendorf DE
Patent application number | Description | Published |
---|---|---|
20160001514 | METHOD AND DEVICE FOR PRODUCING GREEN TIRES - A method and a device for the production of a green tire, in which at least two materials in strip form are positioned on a tire building drum. At least two cores are set in place. The tire building drum is equipped both with a core clamping device and with a core fixing device. The tire building drum is composed of a central part and of two drum halves arranged adjacent to the central part on both sides. The drum halves are arranged such that they can be positioned in an axial direction. The central part is equipped with a variable diameter in a radial direction. A radial enlargement of the diameter of the central part is performed before the cores are set in place. | 01-07-2016 |
Alexander Behrens, Markdorf DE
Patent application number | Description | Published |
---|---|---|
20160026882 | Method for the Operation of an Assistance System of a Motor Vehicle, as well as Assistance System - The invention relates to a method ( | 01-28-2016 |
Andreas Behrens, Huertgenwald DE
Patent application number | Description | Published |
---|---|---|
20140346803 | SEALING ARRANGEMENT FOR VEHICLE WINDOWS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF - A sealing arrangement for vehicle windows is described. The sealing arrangement has at least a holding rail that has a locking channel, which is formed by a guide rail and a resilient leg, and is fastened to a window and a cover that has a guide channel, which is formed by a locking rail and a positioning stop. The guide rail is arranged in the guide channel and the locking rail is latched in the locking channel. A locking hook is latched onto the resilient leg in a projecting region of the locking rail and a resilient element is clamped in the guide channel between a stop face on the underside of the cover and the guide rail. | 11-27-2014 |
Andreas Behrens, Bamberg DE
Patent application number | Description | Published |
---|---|---|
20150245633 | Method and Device for Producing Strip-Shaped Objects, in Particular Sticks of Chewing Gum - The invention relates to a method and device for producing individual strip-shaped objects (strip S), in particular objects that are suitable for consumption, in particular sticks of chewing gum, said method and device having the following method steps and features; supplying substantially rectangular sheets (P), trots which the strip-shaped objects (S) are to be formed, wherein the length of the shorter sides of the sheets (P) corresponds substantially to the length of a strip-shaped object (S) to be formed, and wherein several grooves (R) which extend parallel to one another are arranged at identical spacings in the sheets (P) substantially parallel to the shorter sides of the sheets (P), wherein the spacing between two adjacently arranged grooves (R) in each case corresponds substantially to the width of a strip (S) to be formed; and forming the individual strips (S) from the sheets (P) which are supplied individually consecutively in their longitudinal direction. In this case, the step of forming the individual strips (S) includes in particular the following method steps and features: separating in each case an individual strip (S) from the sheet (P) along the frontmost groove (R) in each case at its front end in the conveying direction; forming a predetermined spacing between the individual consecutive separated strips (S) in the conveying direction for a subsequent onward conveying of the formed strips (S); detecting an actual position of each individual separated strip (S) in the conveying direction during the separation of the strips (S) from the sheet (P); and correcting the position of the individual separated strips (S) in the conveying direction if the detected actual position of the strip (S) does not correspond to a position which matches the predetermined spacing between the individual consecutive strips (S) for a subsequent onward conveying of the formed strips (S). | 09-03-2015 |
Axel Behrens, London GB
Patent application number | Description | Published |
---|---|---|
20150322406 | METHOD FOR REPROGRAMMING SOMATIC CELLS TO PANCREATIC BETA CELLS - The present invention relates to a method for reprogramming a somatic cell (e.g. a pancreatic ductal cell, a skin fibroblast or a keratinocyte) to a pancreatic β-cell. This method involves decreasing expression or activity of Fbw7 and/or decreasing phosphorylation-mediated degradation of NGN3 in the somatic cell. The method may be carried out ex vivo or in vivo. The invention also relates to a method of treating a subject with a metabolic disorder (e.g. diabetes) or a subject at risk of a metabolic disorder by administering somatic cells that have been re-programmed to pancreatic β-cells using methods described herein to the subject. In addition, the invention relates to screening methods for identifying a candidate agent for reprogramming a somatic cell to a pancreatic β-cell. | 11-12-2015 |
Bruce Behrens, Glenbrook New South Wales AU
Patent application number | Description | Published |
---|---|---|
20110259219 | A Method of Printing - The present invention relates to a method of printing on a polymeric film using a gravure printing press, a method of making rollers for a gravure printing press and a set of gravure rollers. The invention enables standardised process colours such as, CYMK colours to be combined to from non-standardised process colours such as, secondary and tertiary colours via a select range of screen angles and screen rulings. | 10-27-2011 |
Carsten Behrens, Koebenhavn N DK
Patent application number | Description | Published |
---|---|---|
20120309944 | Growth Hormones With Prolonged In-Vivo Efficacy - The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there altered profile considered particular useful in therapy. | 12-06-2012 |
20140107324 | Growth Hormones with Prolonged In-Vivo Efficacy - The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there althered profile considered particular useful in therapy. | 04-17-2014 |
Carsten Behrens, Koebenhavn DK
Patent application number | Description | Published |
---|---|---|
20150224203 | Factor VIII Conjugates - The present invention relates to FVIII conjugated to heparosan (HEP) polymers, methods for the manufacture thereof and uses of such conjugates. The resultant conjugates may be used in the treatment or prevention of bleeding disorders such as haemophilia. | 08-13-2015 |
20150225710 | Coagulation Factor IX Conjugates - The present invention relates to Factor IX polypeptides conjugated to heparosan (HEP) polymers, methods for the manufacture thereof and uses of such conjugates. The resultant conjugates may be used—for example—in the treatment or prevention of bleeding disorders such as haemophilia B. | 08-13-2015 |
20150225711 | Factor VII Conjugates - The present invention relates to the conjugation of Factor VII polypeptides with heparosan polymers. The resultant conjugates may be used to deliver Factor VII, for example in the treatment or prevention of bleeding disorder | 08-13-2015 |
20150259665 | FACTOR VII CONJUGATES - The present invention relates to the conjugation of Factor VII polypeptides with heparosan polymers. The resultant conjugates may be used to deliver Factor VII, for example in the treatment or prevention of bleeding disorders. | 09-17-2015 |
Carsten Behrens, Kobenhaven N DK
Carsten Behrens, Copenhagen N DK
Patent application number | Description | Published |
---|---|---|
20090143592 | Glucagon Antagonists/Inverse Agonists - A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity. | 06-04-2009 |
20100028939 | Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest - This invention relates to novel compounds, methods for selective chemical conjugation of protractor molecules and the use thereof for diagnostic and/or therapeutic purposes. | 02-04-2010 |
20100056428 | MODIFIED PROTEINS - Method of conjugating glycoproteins by means of chemical modification is provided as well as new modified glycoproteins. | 03-04-2010 |
20130004524 | Conjugated Proteins - The present invention relates to modified therapeutic proteins, such as e.g. coagula-tion factors. In particular, the present invention relates to conjugated Factor VIII molecules such as e.g. FVII, FVIII, or FIX comprising a hydrophobic side group. | 01-03-2013 |
20130143815 | GROWTH HORMONE CONJUGATES - The present invention relates to growth hormone conjugates comprising a bile acid residue, said conjugation may occur through wt or mutant amino acid residues. The growth hormone polypeptide may be wt human growth hormone or a growth hormone variant. | 06-06-2013 |
20140274903 | USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST - This invention relates to novel compounds, methods for selective chemical conjugation of protractor molecules and the use thereof for diagnostic and/or therapeutic purposes. | 09-18-2014 |
Carsten Behrens, Kobenhavn N DK
Patent application number | Description | Published |
---|---|---|
20080275066 | Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists - The invention provides compounds of formula (I) for use as GLP-1 receptor agonists. | 11-06-2008 |
20090036353 | Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers - Insulin conjugated with structurally well defined, bifurcated and trifurcated polymers can be use by pulmonary delivery for systemic absorption through the lungs to reduce or eliminate the need for administering other insulins by injection. | 02-05-2009 |
20090240028 | Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides - The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein. | 09-24-2009 |
20110223151 | CONJUGATED PROTEINS WITH PROLONGED IN VIVO EFFICACY - The invention relates to conjugated proteins, in particular but not exclusively, blood coagulation factors, to processes for preparing said conjugates, to pharmaceutical compositions comprising said conjugates and to the use of the conjugates in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia. | 09-15-2011 |
20120093840 | TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS - The invention described herein relates to novel molecules and polypeptides comprising at least one amino acid sequence having significant identity with (homology to) human Factor VIII or biologically active portion(s) thereof, related molecules (such as nucleic acids encoding such polypeptides), compositions (such as pharmaceutical formulations) comprising such polypeptides, and methods of making and using such polypeptides. | 04-19-2012 |
20120172303 | Growth Hormones with Prolonged In-Vivo Efficacy - The present invention relates to polypeptide compound optimized for subcutaneous administration, exemplified by growth hormone conjugates having a linker providing non-covalent binding to albumin. | 07-05-2012 |
20120322738 | CONJUGATED FVIII VARIANTS - The present invention relates to conjugated Factor VIII variants. The present invention in particular relates to conjugated FVIII variants comprising different polymeric groups as well as use thereof. | 12-20-2012 |
Christian Behrens, Bremen DE
Patent application number | Description | Published |
---|---|---|
20150109340 | METHOD FOR DEPICTING SAFETY-CRITICAL DATA VIA A DISPLAY UNIT, DISPLAY UNIT - A method for depicting data on the display of a modular display unit is provided. The data to be depicted comprises safety-critical data portions and non-safety-critical data portions data stream and depicted on the display via a graphical to the invention, a safety component of the display unit generates the safety-critical data portions based on safety-critical signals which are supplied to the display unit, while a background component of the display unit generates the non-safety-critical data portions in the form of a background screen. The safety-critical data portions are put on the display over said background screen in that a multiplexer converts the graphical data stream for display between the safety component and the background component, wherein, the specific regions, graphical content of the background screen changes and safety-critical graphical content is introduced and depicted on the display. | 04-23-2015 |
Christian Behrens, Palaisem FR
Patent application number | Description | Published |
---|---|---|
20090263380 | ANTI-IDIOTYPIC ANTIBODIES NEUTRALIZING THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST THE C1 DOMAIN OF FACTOR VIII - The present invention is related to a monoclonal anti-idiotypic antibody directed against a Factor VIII inhibitor antibody binding to the C1 domain of Factor VIII, as well as to a cell line producing this monoclonal anti-idiotypic antibody, to the use of this monoclonal anti-idiotypic antibody as medicament, and more particularly to the use thereof for manufacturing a medicament intended for the treatment of haemophilia A. | 10-22-2009 |
Christian Behrens, Palaiseau FR
Patent application number | Description | Published |
---|---|---|
20090130094 | Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII - The invention relates to an anti-idiotypical antibody targeting an antibody inhibiting the human factor VIII, said inhibiting antibody targeting the C2 region of the human factor VIII, the variable region of each of the light chains thereof being encoded by a sequence of nucleic acids of which at least 70% is identical to the murine sequence of nucleic acids SEQ ID NO: 1, and the variable region of each of the heavy chains thereof being encoded by a sequence of nucleic acids of which at least 70% is identical to the murine sequence of nucleic acids SEQ ID NO: 2, the constant regions of the light chains and the heavy chains being constant regions from a non-murine species. The invention also relates to the use of said antibody for activating the FcγRIII receptors of cytotoxic immune cells, and to the production of a medicament especially for the treatment of haemophilia A. | 05-21-2009 |
20090175789 | Antibody raised against the ldl receptor - The present invention relates to a monoclonal antibody raised against the human LDL (Low Density Lipoprotein) receptor, binding to the peptide corresponding to amino acids 195-222 (SEQ ID NO: 1) in the peptide sequence for the human LDL receptor; to the use thereof as a drug; to a pharmaceutical composition containing this antibody; and to the use thereof in immunohistochemical analyses of cancerous, healthy, or cirrhotic tissues, in Western-Blot or ELISA analyses, or in in vivo quantification tests. | 07-09-2009 |
20100098706 | MONOCLONAL ANTIBODY DIRECTED AGAINST THE HUMAN LDL RECEPTOR - The invention relates to a monoclonal antibody directed against the human LDL (Low Density Lipoprotein) receptor, in which the variable region of each of the light chains is coded by the murine nucleic acid sequence SEQ ID NO: 5, the variable region of each of the heavy chains is coded by the murine nucleic acid sequence SEQ ID NO: 7, or by nucleic acid sequences having a sufficient homology with the sequences SEQ ID NO: 5 and SEQ ID NO: 7 so that the nature and the affinity of the bond between the antibody and its antigene are not modified, while the constant regions of the light chains and the heavy chains thereof are constant regions from a non-murine species. | 04-22-2010 |
20110201033 | G IMMUNOGLOBULIN USED AGAINST ANTHRAX TOXINS - An immunoglobulin of the G class (IgG) directed against the protective antigen (PA) of the anthrax toxin, includes: | 08-18-2011 |
20110274684 | CYTOTOXIC ANTIBODIES DIRECTED AGAINST ANTIBODIES INHIBITING FACTOR VIII - The invention relates to an anti-idiotypical antibody targeting an antibody inhibiting the human fact VIII, said inhibiting antibody targeting the C2 region of the human factor VIII, the variable region of each of the light chains thereof being encoded by a sequence of nucleic acids of which at least 70% is identical to the murine sequence of nucleic acids SEQ ID NO: 1, and the variable region of each of the heavy chains thereof being encoded by a sequence of nucleic acids of which at least 70% is identical to the murine sequence of nucleic acids SEQ ID NO: 2, the constant regions of the light chains and the heavy chains being constant regions from a non-murine species. The invention also relates to the use of said antibody for activating the FcγRIII receptors of cytotoxic immune cells, and to the production of a medicament especially for the treatment of haemophilia A. | 11-10-2011 |
20120009188 | OPTIMIZED FC VARIANTS - A variant of a parent polypeptide including an Fc region, which variant exhibits increased binding to FcRn as compared to the parent polypeptide and includes at least one amino acid modification in the Fc region. | 01-12-2012 |
20130136743 | NOVEL MUTATED HUMANIZED 12G4 ANTIBODIES AND THE FRAGMENTS THEREOF AGAINST THE HUMAN ANTI-MULLERIAN HORMONE RECEPTOR TYPE II - Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor. | 05-30-2013 |
20150232563 | NOVEL MUTATED HUMANIZED 12G4 ANTIBODIES AND THE FRAGMENTS THEREOF AGAINST THE HUMAN ANTI-MULLERIAN HORMONE RECEPTOR TYPE II - Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor. | 08-20-2015 |
Christian Behrens, Bundlesland FR
Patent application number | Description | Published |
---|---|---|
20110318757 | RECOMBINANT ANTI-MUC1 ANTIBODIES - Antibodies having a high specificity and high affinity towards the human gene product MUC1, which in specific variants is associated with neoplastic cells, i.e. tumor tissue, to the use of the antibodies for medical purposes, i.e. for tumor treatment, and for analytical purposes, e.g. for tumor diagnosis. Compositions comprising the antibodies, e.g. for use in the analytical processes and analyses, to pharmaceutical compositions comprising the antibodies, and to use of the antibodies in the manufacture of pharmaceutical compositions for tumor treatment or for diagnostic purposes. | 12-29-2011 |
Collette Behrens, Macquarie Park AU
Patent application number | Description | Published |
---|---|---|
20160068612 | ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B - Antibodies that specifically bind to CD38, as well as constructs comprising such antibodies fused to attenuated interferon alpha-2B proteins are provided. Anti-CD38-attenuated interferon alpha-2b fusion constructs may be used to inhibit proliferation in cancerous cells that express both CD38 and the receptor for IFN-alpha2b, as well as to induce apoptosis in such cells. Inhibition of proliferation and induction of apoptosis in cancerous cells may serve as the basis for the treatment of the underlying cancer. | 03-10-2016 |
Collette Jane Behrens, Macquarie Park AU
Patent application number | Description | Published |
---|---|---|
20150313965 | Combination of Lenalidomide and Polypeptide Construct, and Uses Thereof - Methods for cancer treatment include administering to a cancer patient an anti-CD38 antibody-attenuated human IFN alpha-2b construct and lenalidomide or pomalidomide. Tumors that may be treated according to these methods include tumors which comprise CD-38 expressing tumor cells, including B-cell lymphoma, multiple myeloma, non-Hodgkin's lymphoma, chronic myelogenous leukemia, chronic lymphocytic leukemia, and acute lymphocytic leukemia. | 11-05-2015 |
Frank Herman Behrens, Campinas BR
Patent application number | Description | Published |
---|---|---|
20130318380 | Handling of Wake-Up Messages in Controller Area Networks - Systems and methods for handling wake-up messages in a Controller Area Network (CAN) are described. In some embodiments, a method may include operating a CAN controller in a selected one of a plurality of operating modes in response to the detection of an event or activity on a CAN bus. The method may also include handling, by the CAN controller, a CAN message using a message handling protocol associated with the selected one of the plurality of operating modes, for example, while a host processor operates in a low power mode. In various implementations, each of the plurality of operating modes may correspond to a different amount of power consumption by the CAN controller. The method may further include transmitting a selected one of a plurality of response messages by the CAN controller over the CAN bus, in some cases, without waking up the processor from the low power mode. | 11-28-2013 |
20150237174 | MULTI-FRAME AND FRAME STREAMING IN A CONTROLLER AREA NETWORK (CAN) WITH FLEXIBLE DATA- RATE (FD) - Systems and methods for multi-frame and frame streaming in a Controller Area Network (CAN) with Flexible Data-Rate (FD). In some embodiments, a method may include creating, by a device coupled to a CAN network configured to support a CAN Flexible Data-Rate (FD) protocol, a data frame comprising a field that indicates a multi-frame or streaming transmission, and transmitting the data frame in the multi-frame or streaming transmission. A CAN node may include message processing circuitry configured to receive a data frame comprising a Data Length Code (DLC) field configured to indicate multi-frame operation or streaming operation. The message processing circuitry may be further configured to receive another data frame in the absence of an arbitration process between the data frames. | 08-20-2015 |
20150347218 | INDICATING INTERNAL TRANSMITTER ERRORS IN A CONTROLLER AREA NETWORK (CAN) - Systems and methods for indicating internal transmitter errors in a Controller Area Network (CAN). In some embodiments, a method may include initiating, by a device coupled to a CAN, transmission of a message via the CAN; detecting an error by the device during the transmission; and continuing, by the device after having detected the error, the transmission of the message without causing or indicating a bus error condition. In other embodiments, a CAN node may include message processing circuitry configured to receive a frame from a transmitter, the frame comprising a cyclic redundancy check (CRC) field, the message processing circuitry further configured to identify an internal error of the transmitter based upon the CRC field. | 12-03-2015 |
Jonas Behrens, Hyllinge SE
Patent application number | Description | Published |
---|---|---|
20150041575 | GYRATORY CRUSHER BEARING - A gyratory crusher bearing includes a bearing surface to support rotational movement of a crushing head, wherein a shape profile of the bearing surface at a cross section of the bearing perpendicular to a longitudinal axis of the bearing is substantially circular. A mounting surface is positioned against a bearing support and is orientated to be outward facing relative to the longitudinal axis. A bearing wall is defined between the mounting surface and the bearing surface, the bearing surface defining a central bore extending between a first edge end and a second edge end of the wall. At least one region of the mounting surface in combination with the bearing surface defines the wall between the first edge end and the second edge end and includes a shape profile at a cross section of the bearing perpendicular to the longitudinal axis that is non-circular to define an anchorage region to inhibit rotation of the bearing about the longitudinal axis relative to the bearing support. | 02-12-2015 |
Juergen Behrens, Harpstedt DE
Patent application number | Description | Published |
---|---|---|
20160102020 | LINOLEUM COMPOSITION WITH HYDROPHOBIC ADDITIVE - A linoleum composition comprising Bedford cement as a binder, wood flour as a filler, and wax in an amount effective to provide the wood flour filler with hydrophobic properties. | 04-14-2016 |
20160102428 | AESTHETICALLY PLEASING LINOLEUM BASED SURFACE COVERINGS - Described herein are surface coverings comprising a carrier, a first linoleum composition, and a second linoleum composition; wherein the flow rate of the first linoleum composition is greater than the flow rate of the second linoleum composition. | 04-14-2016 |
Marcel Behrens, Vilvoorde BE
Patent application number | Description | Published |
---|---|---|
20130306650 | METHOD OF AND APPARATUS FOR MEASURING THE TRUE CONTENTS OF A CYLINDER OF GAS UNDER PRESSURE - There is provided a method of and apparatus for, measuring the mass of a gas under pressure using a piezoelectric oscillator. The gas is contained within a pressure vessel ( | 11-21-2013 |
20130333774 | METHOD OF AND APPARATUS FOR MEASURING THE PRESSURE OF A GAS - There is provided a pressure gauge for measuring the pressure of a gas. The pressure gauge comprises a housing connectable to the gas source and comprising an interior which is, in use, in communication with said gas. The pressure gauge further comprising a sensor assembly located within said housing and including a piezoelectric oscillator which, in use, is located in contact with said gas, said sensor assembly being arranged to measure the oscillation frequency of said piezoelectric oscillator in said gas and configured to determine, from the frequency measurement and the known temperature and known molecular weight of the gas, the pressure of the gas. By providing such an arrangement, an overpressure proof yet accurate pressure gauge can be provided. This is in contrast to conventional gauges which are damaged permanently by overpressure situations. | 12-19-2013 |
Markus Behrens, Monnaz CH
Patent application number | Description | Published |
---|---|---|
20130165930 | BOLT AND TOOL WITH ANTI-TORQUE FEATURES - A system for fixing a wire to a surface of an external fixator having a wire adapted to extend through bony structure fastened with respect to the surface. A bolt having a shaft which comprises a threaded section, a head section and at least one clamping element is provided wherein the bolt is adapted to extend through an opening in the external fixation element with a nut, and clamps the wire to the surface. A counter torque tool is used to provide a counter torque while fastening the wire with the bolt and the nut. The bolt comprises a counter torque opening and wherein the counter torque tool comprises a section which is adapted to engage into the counter torque opening of the bolt to apply the counter torque. | 06-27-2013 |
Meinhard Behrens, Wiedensahl DE
Patent application number | Description | Published |
---|---|---|
20140339874 | ADJUSTMENT DRIVE OF A MOTOR VEHICLE SEAT - An adjustment drive of a motor vehicle seat is provided, the adjustment drive, having a control pinion. The control pinion, in the event of a collision, is subjected to a torque which acts from the structure of the motor vehicle seat. Overload protection is provided for an adjustment drive of a motor vehicle seat against forces which act in the event of a collision, using a simple device. This is achieved by the control pinion being rigidly connected to a torsion bar, and the control pinion is situated in an extension of the rotational axis of the control pinion, and free end of the torsion bar being integrated into a drive of the control pinion in a rotationally fixed manner. | 11-20-2014 |
20150375647 | VEHICLE SEAT, IN PARTICULAR FOR A MOTOR VEHICLE - Vehicle seat, in particular, for a motor vehicle, has a seat cushion to accommodate a person, and a support member protecting a person on the seat cushion against sliding beneath a seat belt. There is an adjustment device for adjusting the support member relative to the seat cushion. The adjustment device for adjusting the support member is provided between a default position and an activated position depending on a position of the seat cushion relative to another component. The relative position may be, in particular, a vertical or longitudinal position. | 12-31-2015 |
Michael Behrens, Harburg DE
Patent application number | Description | Published |
---|---|---|
20150360779 | EXTERNAL LOAD MASS ROPE OF A ROTORCRAFT - An external load mass rope for attachment to a cargo hook device of a rotorcraft that comprises at least one first cargo hook and at least one second cargo hook, the external load mass rope comprising at least one first rope leg and at least one second rope leg, wherein the at least one first rope leg is adapted for attachment to the at least one first cargo hook and the at least one second rope leg is adapted for attachment to the at least one second cargo hook, characterized in that at least one of the first and second rope legs comprises an associated length adjustment unit that is adapted to shorten or lengthen the at least one of the first and second rope legs in operation on the basis of associated operating parameters. | 12-17-2015 |
Michael Behrens, Münster DE
Patent application number | Description | Published |
---|---|---|
20150285078 | ROTOR AND FLUID TURBINE WITH ROTOR | 10-08-2015 |
20150285208 | FLUID TURBINE - A fluid turbine | 10-08-2015 |
20150285219 | ROTOR AND FLUID TURBINE WITH ROTOR | 10-08-2015 |
Michael Behrens, Berowra AU
Patent application number | Description | Published |
---|---|---|
20140083788 | Step-Climbing Attachment for a Wheeled Chair - A step climbing attachment suitable for attachment to a wheeled chair is described. The step climbing attachment includes a chassis for mounting one or more ground engaging units, a first and a second ground engaging unit mounted to the chassis, at least one of the first and second ground engaging units adapted to move relative to the other of the first or second ground engaging units and the chassis, the relative movement being between a ground engaging position and a step-engaging support position so that in use at least one of the first and/or second ground engaging units engages a step. | 03-27-2014 |
20150129328 | Step-Climbing Attachment for a Wheeled Chair - A step climbing attachment suitable for attachment to a wheeled chair is described. The step climbing attachment includes a chassis for mounting one or more ground engaging units, a first and a second ground engaging unit mounted to the chassis, at least one of the first and second ground engaging units adapted to move relative to the other of the first or second ground engaging units and the chassis, the relative movement being between a ground engaging position and a step-engaging support position so that in use at least one of the first and/or second ground engaging units engages a step. | 05-14-2015 |
Peter Behrens, London GB
Patent application number | Description | Published |
---|---|---|
20130226766 | RETAIL CONTRACT MATCHING SYSTEM - A matching mechanism for matching entities in an exchange, the entities being based on disparate criteria, the mechanism including a first input from a first set of users adapted to submit to a processor a first criterion from a first set of criteria relevant to the first set of users, which first criterion characterises an entity to be matched. The mechanism including a second input from a second set of users adapted to submit to the processor a second criterion from a second set of criteria relevant to the second set of users, which second criterion characterises another entity to be matched, wherein the first and second criteria are different. The processor is programmed to transform the first criterion into first data of a third criterion, transform the second criterion into second data of the third criterion, compare the first and second data of the third criterion and flag a match between the two entities if the first and second data of the third criteria match. | 08-29-2013 |
Sam Behrens, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20090127976 | Method and Apparatus for Harvesting Energy from Mechanical Vibrations - A method of harvesting energy from a vibrational energy source having a varying energy characteristic. The method includes the step of varying a characteristic of a harvesting arrangement arranged to harvest the energy, the characteristic of the harvesting arrangement being varied in response to the varying energy characteristic of the vibrational energy source. | 05-21-2009 |
Tim Behrens, Kobenhavn S DK
Patent application number | Description | Published |
---|---|---|
20120224965 | CONTROL OF WIND TURBINE BLADE LIFT REGULATING MEANS - The invention involves a wind turbine comprising at least one blade ( | 09-06-2012 |
Tim Behrens, Valby DK
Patent application number | Description | Published |
---|---|---|
20120068469 | WIND TURBINE ROTOR BLADE - A wind turbine blade extending in a longitudinal direction from a root end to a tip end and defining an aerodynamic airfoil cross-section between a leading edge and a trailing edge in a chordwise direction transverse to the longitudinal direction, the aerodynamic airfoil cross-section having an effective camber in the chordwise direction; the wind turbine blade comprising: blade body; first device for modifying the aerodynamic surface or shape of the blade, the position and/or movement of the first device relative to the blade body being controlled by a first actuation mechanism; second device for modifying the effective camber of the airfoil cross section; herein, in use, the first device modifies the aerodynamic surface or shape of the blade at a frequency up to a first maximum frequency and the second device modifies the effective camber of the airfoil cross section at a frequency up to a second maximum frequency, the second maximum frequency being higher than the first maximum frequency. | 03-22-2012 |